Although a weaker insulin-sensitizing effect than in women with non-autoimmune subclinical disease suggests that this agent may be a less effective diabetes prevention strategy in case of concurrent thyroid autoimmunity, young women with autoimmune hypothyroidism may also benefit from treatment with metformin. This evidence concerns the gene INS and diabetes mellitus.